CompaniesPharmagen Laboratories

Pharmagen Laboratories

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

3

As Collaborator

2

Total Enrollment

4,999

By Phase

NA: 1PHASE3: 1PHASE4: 3

By Status

COMPLETED: 4UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT00910832
Hover over trial bars to see details

Recent Trials

NCT04567953Lead Sponsor
COVID-19 Tests With Saliva Specimens
NAUnknown
2,000 participants
Started: Jul 28, 2020 · Completed: Jun 27, 2021
NCT04304053Collaborator
Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention
PHASE3Completed
2,300 participants
Started: Mar 18, 2020 · Completed: Jun 15, 2020
NCT03410862Collaborator
Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza
PHASE4Completed
87 participants
Started: Jan 29, 2018 · Completed: Jun 25, 2019
NCT01243723Lead Sponsor
Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia
PHASE4Completed
306 participants
Started: Nov 30, 2010 · Completed: Jun 30, 2012
NCT00910832Lead Sponsor
Efficacy of Eductyl® Versus Placebo for Treatment of Dyschesia
PHASE4Completed
306 participants
Started: May 31, 2009 · Completed: Jun 30, 2012